No Data
No Data
Hoping for a Weight-loss Pill? It Could Be Closer to Reality Next Week.
Express News | Madrigal Pharmaceuticals Shares up 11%, Akero Therapeutics Gains 6% and Viking Therapeutics Shares Rise 2%
Express News | Shares of Some Liver Disease Drugmakers Rise Between 2% and 11% ; Late-Stage Data From Novo's Weight-Loss Drug Shows Improvement in Fatty Liver Disease
Viking Therapeutics to Participate at Upcoming Investor Conferences
Unpacking the Latest Options Trading Trends in Viking Therapeutics
StoneTree Investment Partners Invests in Viking Engineering
No Data
No Data